rs34883113
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_000558.5(HBA1):c.96-1G>A variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000558.5 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HBA1 | ENST00000320868.9 | c.96-1G>A | splice_acceptor_variant, intron_variant | Intron 1 of 2 | 1 | NM_000558.5 | ENSP00000322421.5 | |||
HBA1 | ENST00000472694.1 | n.231G>A | non_coding_transcript_exon_variant | Exon 1 of 2 | 1 | |||||
HBA1 | ENST00000487791.1 | n.65-1G>A | splice_acceptor_variant, intron_variant | Intron 1 of 1 | 1 | |||||
HBA1 | ENST00000397797.1 | c.-1-1G>A | splice_acceptor_variant, intron_variant | Intron 1 of 2 | 2 | ENSP00000380899.1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 9AN: 149540Hom.: 0 Cov.: 29 FAILED QC
GnomAD3 exomes AF: 0.000171 AC: 22AN: 128456Hom.: 0 AF XY: 0.000230 AC XY: 16AN XY: 69530
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000821 AC: 75AN: 913436Hom.: 0 Cov.: 12 AF XY: 0.000126 AC XY: 59AN XY: 468384
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000601 AC: 9AN: 149660Hom.: 0 Cov.: 29 AF XY: 0.0000959 AC XY: 7AN XY: 73016
ClinVar
Submissions by phenotype
not provided Pathogenic:2
The HBA1 c.96-1G>A variant, also known as IVS-I-117G>A), disrupts a canonical splice-acceptor site and interferes with normal HBA1 mRNA splicing. In the published literature, this variant is associated with alpha-thalassemia (PMID: 8251382 (1993), 22738642 (2012), and HbVar (http://globin.cse.psu.edu/cgi-bin/hbvar/counter)) and has been reported an individual with Hb H disease who was also positive for the --SEA alpha-globin deletion (PMID: 31693295 (2020)). Based on the available information, this variant is classified as pathogenic. -
The HBA1 c.96-1G>A variant (rs34883113, HbVar ID: 1067), also known as alpha1 IVS-I-117 (G->A), has been reported in multiple individuals affected with alpha thalassemia minor, found in-trans with either an alpha globin deletion or homozygously (Curuk 1993, HbVar database). This variant is found in the South Asian population with an overall allele frequency of 0.10% (21/21318 alleles) in the Genome Aggregation Database. This variant abolishes the canonical splice acceptor site of intron 1, which is likely to disrupt gene function. Based on available information, this variant is considered to be pathogenic. References: Link to HbVar : http://globin.bx.psu.edu/ Curuk M et al. An IVS-I-117 (G-->A) acceptor splice site mutation in the alpha 1-globin gene is a nondeletional alpha-thalassaemia-2 determinant in an Indian population. Br J Haematol. 1993; 85(1):148-52. PMID: 8251382. -
HBA1-related disorder Pathogenic:1
The HBA1 c.96-1G>A variant is predicted to disrupt the AG splice acceptor site and interfere with normal splicing. This variant (also referred to as IVS-I-117) has been reported as a founder variant in the Indian population and is causative for alpha thalassemia (Curuk. 1993. PubMed ID: 8251382; Scheps. 2012. PubMed ID: 22738642). This variant is also interpreted as likely pathogenic and pathogenic in ClinVar. This variant is interpreted as pathogenic. -
alpha Thalassemia Pathogenic:1
PVS1, PS3, PP5 -
alpha Thalassemia;C0700299:Heinz body anemia;C3161174:Hemoglobin H disease;C4693798:Methemoglobinemia, alpha type;C4693823:Erythrocytosis, familial, 7 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at